Hunter C A, Bermudez L, Beernink H, Waegell W, Remington J S
Department of Immunology and Infectious Diseases, Palo Alto Medical Foundation, California, USA.
Eur J Immunol. 1995 Apr;25(4):994-1000. doi: 10.1002/eji.1830250420.
Severe-combined immune deficient (SCID) mice have been found to resist infection with the intracellular protozoan parasite Toxoplasma gondii via interleukin (IL)-12 stimulation of interferon (IFN)-gamma production by natural killer (NK) cells. Previously, we demonstrated the presence of increased levels of transcripts for transforming growth factor-beta (TGF-beta) in the brains and lungs of SCID mice infected with T. gondii, leading us to investigate the role of TGF-beta in the mechanism of resistance to T. gondii in these mice. Stimulation of splenocytes from SCID mice with heat-killed T. gondii resulted in production of low levels of IFN-gamma and a two to threefold increase in levels of TGF-beta in the culture supernatants. Production of IFN-gamma in these cultures was increased three to fourfold by addition of anti-TGF-beta antibody. Stimulation of splenocytes from SCID mice with IL-12 in combination with either TNF-alpha or IL-1 beta resulted in production of high levels of IFN-gamma. Addition of TGF-beta to these cultures inhibited production of IFN-gamma in a dose-dependent manner. Immunohistochemical studies revealed increased levels of TGF-beta protein in the spleens of SCID mice 5 days after oral infection with the ME49 strain of T gondii, and brains of SCID mice at 18 days post-infection. However, no difference was detected in the levels of TGF-beta transcripts in the spleens of uninfected mice or mice infected for 5 days. To test whether TGF-beta could antagonize IL-12 mediated resistance to T. gondii in vivo, we administered TGF-beta to SCID mice infected with T. gondii. This treatment resulted in earlier mortality of infected mice and significantly reduced the ability of exogenous IL-12 to delay time-to-death. Administration of anti-TGF-beta to SCID mice, beginning 24 h prior to infection and every 2 days thereafter, delayed significantly time-to-death. Together, our data demonstrate that TGF-beta antagonizes the ability of IL-12 to stimulate production of IFN-gamma by splenocytes from SCID mice, and suggest a role for TGF-beta in regulation of T cell-independent resistance to T. gondii.
严重联合免疫缺陷(SCID)小鼠已被发现可通过白细胞介素(IL)-12刺激自然杀伤(NK)细胞产生干扰素(IFN)-γ来抵抗细胞内原生动物寄生虫刚地弓形虫的感染。此前,我们证明了感染刚地弓形虫的SCID小鼠的脑和肺中转化生长因子-β(TGF-β)转录本水平升高,这促使我们研究TGF-β在这些小鼠抵抗刚地弓形虫机制中的作用。用热灭活的刚地弓形虫刺激SCID小鼠的脾细胞,导致培养上清液中产生低水平的IFN-γ,且TGF-β水平增加两到三倍。通过添加抗TGF-β抗体,这些培养物中IFN-γ的产生增加了三到四倍。用IL-12联合TNF-α或IL-1β刺激SCID小鼠的脾细胞,导致产生高水平的IFN-γ。向这些培养物中添加TGF-β以剂量依赖的方式抑制IFN-γ的产生。免疫组织化学研究显示,口服刚地弓形虫ME49株感染5天后,SCID小鼠脾脏中TGF-β蛋白水平升高,感染18天后,SCID小鼠脑内TGF-β蛋白水平升高。然而,未感染小鼠或感染5天的小鼠脾脏中TGF-β转录本水平未检测到差异。为了测试TGF-β是否能在体内拮抗IL-12介导的对刚地弓形虫的抗性,我们将TGF-β给予感染刚地弓形虫的SCID小鼠。这种处理导致感染小鼠更早死亡,并显著降低外源性IL-12延迟死亡时间的能力。在感染前24小时开始并在此后每2天向SCID小鼠施用抗TGF-β,显著延迟了死亡时间。总之,我们的数据表明TGF-β拮抗IL-12刺激SCID小鼠脾细胞产生IFN-γ的能力,并提示TGF-β在调节对刚地弓形虫的非T细胞依赖性抗性中起作用。